Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,979.00
Bid: 1,988.00
Ask: 1,990.00
Change: 8.00 (0.41%)
Spread: 2.00 (0.101%)
Open: 1,973.00
High: 1,996.00
Low: 1,955.00
Prev. Close: 1,971.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: Bank Of America Downgrades Morrisons

Mon, 06th Jan 2020 09:37

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

----------

FTSE 100

----------

BANK OF AMERICA CUTS WM MORRISON SUPERMARKETS TO 'UNDERPERFORM' ('NEUTRAL')

----------

GOLDMAN SACHS RAISES BP PRICE TARGET TO 750 (730) PENCE - 'CONVICTION BUY LIST'

----------

MORGAN STANLEY RAISES GLAXOSMITHKLINE PRICE TARGET TO 1740 (1640) PENCE - 'UNDERWEIGHT'

----------

MORGAN STANLEY RAISES ASTRAZENECA PRICE TARGET TO 8100 (7400) PENCE - 'EQUAL-WEIGHT'

----------

SOCGEN CUTS NEXT TO 'SELL' ('HOLD') - TARGET 6588 (6301) PENCE

----------

BERNSTEIN RAISES DIAGEO PRICE TARGET TO 3400 (3250) PENCE - 'MARKET-PERFORM'

----------

BARCLAYS RAISES ASHTEAD GROUP PRICE TARGET TO 3195 (2430) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES GLAXOSMITHKLINE PRICE TARGET TO 1900 (1700) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES ASTRAZENECA PRICE TARGET TO 8500 (7900) PENCE - 'OVERWEIGHT'

----------

JPMORGAN CUTS HIKMA PHARMACEUTICALS TO 'UNDERWEIGHT' ('NEUTRAL') - TARGET 1850 (1800) PENCE

----------

DEUTSCHE BANK RAISES AVIVA PRICE TARGET TO 470 (450) PENCE - 'HOLD'

----------

DEUTSCHE BANK RAISES HARGREAVES LANSDOWN PRICE TARGET TO 1800 (1700) PENCE - 'HOLD'

----------

DEUTSCHE BANK RAISES LEGAL & GENERAL PRICE TARGET TO 335 (290) PENCE - 'BUY'

----------

DEUTSCHE BANK RAISES STANDARD LIFE PRICE TARGET TO 320 (265) PENCE - 'HOLD'

----------

DEUTSCHE BANK CUTS ST JAMES'S PLACE TO 'HOLD' ('BUY') - TARGET 1220 (1190) PENCE

----------

DEUTSCHE BANK RAISES PRUDENTIAL PRICE TARGET TO 1500 (1450) PENCE - 'HOLD'

----------

FTSE 250

----------

UBS RAISES SHAFTESBURY PRICE TARGET TO 915 (860) PENCE - 'NEUTRAL'

----------

UBS RAISES GREAT PORTLAND PRICE TARGET TO 965 (830) PENCE - 'BUY'

----------

UBS RAISES DERWENT LONDON PRICE TARGET TO 4425 (3750) PENCE - 'BUY'

----------

JPMORGAN CUTS ASTON MARTIN LAGONDA PRICE TARGET TO 500 (570) PENCE - 'NEUTRAL'

----------

JEFFERIES RAISES SERCO GROUP PRICE TARGET TO 185 (170) PENCE - 'BUY'

----------

JEFFERIES RAISES MARKS & SPENCER PRICE TARGET TO 230 (207) PENCE - 'HOLD'

----------

JEFFERIES RAISES HAYS PRICE TARGET TO 165 (145) PENCE - 'HOLD'

----------

JEFFERIES CUTS PAGEGROUP TO 'HOLD' ('BUY') - TARGET 555 (540) PENCE

----------

OTHER MAIN MARKET AND AIM

----------

BARCLAYS RAISES JOHNSON SERVICE GROUP TARGET TO 220 (210) PENCE - 'OVERWEIGHT'

----------

DEUTSCHE BANK RAISES JUST GROUP PRICE TARGET TO 70 (54) PENCE - 'HOLD'

----------

JEFFERIES CUTS GAMMA COMMUNICATIONS TO 'HOLD' (BUY) - TARGET 1280 (1320) PENCE

----------

BERENBERG RAISES ON THE BEACH GROUP PRICE TARGET TO 540 (480) PENCE - 'BUY'

----------

BERENBERG RAISES HOLLYWOOD BOWL PRICE TARGET TO 310 (280) PENCE - 'BUY'

----------

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
21 Jun 2021 14:51

UPDATE 1-U.S. Supreme Court denies Amarin's bid to revive Vascepa drug patents

(Adds background to case, paragraphs 4-10)By Blake BrittainWASHINGTON, June 21 (Reuters) - The U.S. Supreme Court on Monday rejected a bid by an Amarin Corp PLC subsidiary to revive patents on its heart drug Vascepa in a legal battle against gener...

Read more
21 Jun 2021 14:31

U.S. Supreme Court denies Amarin's bid to revive Vascepa drug patents

WASHINGTON, June 21 (Reuters) - The U.S. Supreme Court on Monday rejected a bid by an Amarin Corp PLC subsidiary to revive patents on its heart drug Vascepa in a legal battle against generic drugmakers Hikma Pharmaceuticals PLC and Dr. Reddy's La...

Read more
8 Jun 2021 13:54

Tuesday broker round-up

(Sharecast News) - tinyBuild: Berenberg reiterates buy with a target price of 295p.

Read more
6 May 2021 09:46

BROKER RATINGS: Exane BNP downgrades three property companies

BROKER RATINGS: Exane BNP downgrades three property companies

Read more
30 Apr 2021 17:01

LONDON MARKET CLOSE: Stocks close out impressive April to end higher

LONDON MARKET CLOSE: Stocks close out impressive April to end higher

Read more
30 Apr 2021 08:58

TOP NEWS: Hikma Pharma confident after promising start to year

TOP NEWS: Hikma Pharma confident after promising start to year

Read more
30 Apr 2021 07:57

LONDON MARKET PRE-OPEN: Barclays, AstraZeneca post sharp profit rises

LONDON MARKET PRE-OPEN: Barclays, AstraZeneca post sharp profit rises

Read more
30 Apr 2021 07:38

Hikma predicts generics revenue at top of guidance

(Sharecast News) - Hikma Pharmaceutical said it made a good start to 2021 and that annual revenue from generic treatments would be at the top of guidance.

Read more
23 Apr 2021 16:01

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
21 Apr 2021 12:08

LONDON MARKET MIDDAY: Stocks recover modestly; Netflix misses targets

LONDON MARKET MIDDAY: Stocks recover modestly; Netflix misses targets

Read more
21 Apr 2021 10:06

Hikma resumes asthma drug launch, Vectura pays special dividend

Hikma resumes asthma drug launch, Vectura pays special dividend

Read more
21 Apr 2021 09:01

LONDON MARKET OPEN: Stocks rise; Just Eat sinks on Germany competition

LONDON MARKET OPEN: Stocks rise; Just Eat sinks on Germany competition

Read more
21 Apr 2021 07:52

LONDON MARKET PRE-OPEN: Anto holds outlook, BHP cuts coal guidance

LONDON MARKET PRE-OPEN: Anto holds outlook, BHP cuts coal guidance

Read more
21 Apr 2021 07:30

Hikma resumes US launch of 'Advair Diskus' generic

(Sharecast News) - Hikma Pharmaceuticals has resumed the launch of its generic version of GlaxoSmithKline's 'Advair Diskus' in the United States, it announced on Wednesday, following Food and Drug Administration (FDA) approval of an amendment it submitted to its Abbreviated New Drug Application in January.

Read more
19 Apr 2021 16:02

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.